Cargando...
Trends in Neoadjuvant Endocrine Therapy Use and Impact on Rates of Breast Conservation in Hormone Receptor Positive Breast Cancer: A National Cancer Data Base Study
BACKGROUND: ACOSOG Z1031 demonstrated that neoadjuvant endocrine therapy (NET) increased breast conserving surgery (BCS) rates for postmenopausal patients with clinical tumor stage 2–4c estrogen receptor positive breast cancer. We evaluated national trends in NET use in relation to Z1031 trial condu...
Guardado en:
| Publicado en: | Ann Surg Oncol |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2016
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5437722/ https://ncbi.nlm.nih.gov/pubmed/27663568 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-016-5585-5 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|